681. rDNA-AAV Vectors for the Treatment of Phenylketonuria

Molecular Therapy - United States
doi 10.1016/s1525-0016(16)38122-9
Full Text
Abstract

Available in full text

Date
Authors

Unknown

Publisher

Elsevier BV

Related search

Treatment of Phenylketonuria

Journal of Pediatrics
Child HealthPediatricsPerinatology
1967English

Intrathecal Administration of AAV Vectors for the Treatment of Lysosomal Storage in the Brains of MPS I Mice

Gene Therapy
Molecular MedicineGeneticsMolecular Biology
2006English

GluA4-targeted AAV Vectors Deliver Genes Selectively to Interneurons While Relying on the AAV Receptor for Entry

Molecular Therapy - Methods and Clinical Development
Molecular MedicineGeneticsMolecular Biology
2019English

Termination of Dietary Treatment for Phenylketonuria

JAMA - Journal of the American Medical Association
Medicine
1963English

Engineered AAV Vectors for Improved Central Nervous System Gene Delivery

Neurogenesis
Developmental NeuroscienceDevelopmental Biology
2015English

The Dietary Treatment of Phenylketonuria

International Journal of Food Sciences and Nutrition
Food Science
1959English

Nanobody-Enhanced Targeting of AAV Gene Therapy Vectors

Molecular Therapy - Methods and Clinical Development
Molecular MedicineGeneticsMolecular Biology
2019English

Assaying the Stability and Inactivation of AAV Serotype 1 Vectors

Human gene therapy methods
Applied MicrobiologyBiotechnologyGeneticsPharmacologyMolecular Medicine
2017English

Conventional Phenylketonuria Treatment

Journal of Inborn Errors of Metabolism and Screening
Child HealthGeneticsEndocrinologyPerinatologyPediatricsMetabolismDiabetes
2016English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy